"10.1371_journal.pone.0052238","plos one","2012-12-20T00:00:00Z","Tobias Bracht; Andrea Federspiel; Susanne Schnell; Helge Horn; Oliver Höfle; Roland Wiest; Thomas Dierks; Werner Strik; Thomas J Müller; Sebastian Walther","University Hospital of Psychiatry, University of Bern, Bern, Switzerland; Department of Psychiatric Neurophysiology, University of Bern, Bern, Switzerland; Department of Diagnostic Radiology, Medical Physics, University Medical Centre Freiburg, Freiburg, Germany; Departments of Radiology and Biomedical Engineering, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America; Institute of Diagnostic and Interventional Neuroradiology, University of Bern, Bern, Switzerland","Conceived and designed the experiments: SW HH. Performed the experiments: OH SW. Analyzed the data: TB SW. Contributed reagents/materials/analysis tools: OH SW. Wrote the paper: TB SS. Interpretation of data: TB AF SS HH OH RW TD WS TJM SW. Critical revision and final approval of the article: TB AF SS HH OH RW TD WS TJM SW.","Dr. Horn has received speaker's fees from Eli-Lilly, Bristol-Myers-Squibb, Lundbeck, Boehringer-Ingelheim and Vifor. Prof. Strik received speaker's fees from/is advisory board member of Eli-Lilly, Pfizer and Lundbeck. Prof. Müller has received research support from Eli-Lilly, speaker's fees from AstraZeneca, Bristol-Myers-Squibb, Janssen-Cilag, Eli-Lilly, Pfizer, Sanofi-Aventis, Glaxo-Smith-Kline, Desitin-Pharma and Vifor. Prof. Müller is advisory board member of Eli-Lilly, Janssen-Cillag, Board Sandoz and Lundbeck; he has been a consultant to Janssen-Cilag and Glaxo-Smith-Kline. Dr. Walther received speakers fees from Sandoz and Janssen-cilag. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","12","Tobias Bracht","TB",10,TRUE,2,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
